Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2,198.00
  • Today's Change18.00 / 0.83%
  • Shares traded8.48m
  • 1 Year change48.56%
  • Beta0.7079
Data delayed at least 20 minutes, as of Feb 06 2026 14:54 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
ASSETS
Cash And Short Term Investments3,4063,7144,992
Total Receivables, Net7,7596,9357,403
Total Inventory5,9245,6695,498
Prepaid expenses--390355
Other current assets, total421289396
Total current assets17,51016,99718,644
Property, plant & equipment, net10,04810,0739,957
Goodwill, net7,0186,9826,811
Intangibles, net16,74815,51514,768
Long term investments1,1261,1961,192
Note receivable - long term--1,044950
Other long term assets2,1481.00--
Total assets61,11859,46359,005
LIABILITIES
Accounts payable--3,4623,717
Accrued expenses--10,36710,711
Notes payable/short-term debt--7621,006
Current portion long-term debt/capital leases3,0121,5871,807
Other current liabilities, total2,9985,5193,827
Total current liabilities21,39121,69721,068
Total long term debt14,70814,63715,205
Total debt17,72016,98618,018
Deferred income tax291382311
Minority interest(421)(585)(552)
Other liabilities, total8,7729,6619,626
Total liabilities44,74145,79245,658
SHAREHOLDERS EQUITY
Common stock1,3491,3481,348
Additional paid-in capital3,4983,4733,451
Retained earnings (accumulated deficit)11,5309,9259,368
Treasury stock - common------
Unrealized gain (loss)--(659)(510)
Other equity, total--(19)(22)
Total equity16,37713,67113,347
Total liabilities & shareholders' equity61,11859,46359,005
Total common shares outstanding4,0754,1454,056
Treasury shares - common primary issue240169256
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.